Fabio
72 lines
3.1 KiB
Markdown
72 lines
3.1 KiB
Markdown
---
|
||
type: "Bill"
|
||
title: "Public Health - Prescription Drug Monitoring Program - Naloxone Medication Data"
|
||
description: "Public Health - Prescription Drug Monitoring Program - Naloxone Medication Data"
|
||
jurisdiction: "us/states/md"
|
||
legislature: "Maryland General Assembly"
|
||
session: "2022"
|
||
identifier: "SB 200"
|
||
citation: "Maryland SB 200 (2022)"
|
||
classification: ["bill"]
|
||
subjects: []
|
||
status: "enacted"
|
||
primary_sponsors: []
|
||
version_count: 3
|
||
action_count: 14
|
||
vote_count: 2
|
||
first_action: "2021-10-05"
|
||
last_action: "2022-04-21"
|
||
source: "openstates"
|
||
source_identifier: "ocd-bill/6f828c73-4575-4295-a4f7-eb8c9cd9cd3e"
|
||
source_url: "http://mgaleg.maryland.gov/mgawebsite/Legislation/Details/sb0200?ys=2022RS&search=True"
|
||
source_hash: "496a1fc10c654588760b3b8d037f2c91b65abda895d7233699cbf3586959bc61"
|
||
vintage: "2026-07-01"
|
||
source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
|
||
retrieved_at: "2026-07-06"
|
||
confidence: "reported"
|
||
tags: ["legislation", "bill", "us-md"]
|
||
---
|
||
|
||
# Maryland SB 200 (2022) — Public Health - Prescription Drug Monitoring Program - Naloxone Medication Data
|
||
|
||
## Version chain
|
||
|
||
The bill's text revisions, in order — the diff chain from filing to enrollment.
|
||
|
||
1. **Chapter - Public Health - Prescription Drug Monitoring Program - Naloxone Medication Data** (committee substitute) — [source](http://mgaleg.maryland.gov/2022RS/Chapters_noln/CH_224_sb0200t.pdf)
|
||
2. **First - Public Health - Prescription Drug Monitoring Program - Naloxone Medication Data** (committee substitute) — [source](http://mgaleg.maryland.gov/2022RS/bills/sb/sb0200f.pdf)
|
||
3. **Third - Public Health - Prescription Drug Monitoring Program - Naloxone Medication Data** (committee substitute) — [source](http://mgaleg.maryland.gov/2022RS/bills/sb/sb0200t.pdf)
|
||
|
||
## Votes
|
||
|
||
- On Third Reading — **134–0** (pass) · lower
|
||
- On Third Reading — **45–0** (pass) · upper
|
||
|
||
## Sponsors
|
||
|
||
- Chair, Finance Committee — primary (organization)
|
||
|
||
## Timeline
|
||
|
||
The legislative action history — every referral, reading, and vote.
|
||
|
||
- **2021-10-05** Pre-filed `introduction`
|
||
- **2022-01-12** First Reading Finance `referral-committee`
|
||
- **2022-01-08** Hearing 1/27 at 2:00 p.m.
|
||
- **2022-02-07** Favorable Report by Finance `committee-passage-favorable`
|
||
- **2022-02-08** Favorable Adopted `committee-passage-favorable`
|
||
- **2022-02-08** Second Reading Passed
|
||
- **2022-02-10** Third Reading Passed `passage`
|
||
- **2022-02-17** Referred Health and Government Operations `referral-committee`
|
||
- **2022-03-23** Hearing 3/30 at 1:30 p.m.
|
||
- **2022-04-07** Favorable Report by Health and Government Operations `committee-passage-favorable`
|
||
- **2022-04-08** Favorable Adopted Second Reading Passed `committee-passage-favorable`
|
||
- **2022-04-11** Third Reading Passed `passage`
|
||
- **2022-04-11** Returned Passed
|
||
- **2022-04-21** Approved by the Governor - Chapter 224 `executive-signature`
|
||
|
||
## Source
|
||
|
||
OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/6f828c73-4575-4295-a4f7-eb8c9cd9cd3e`. Confidence: reported (aggregated from official Maryland legislature records).
|
||
|